Alnylam Pharmaceuticals
Melanie Schreiner, MS, RAC, is a seasoned professional in regulatory affairs, currently serving as Sr. Manager of Regulatory Affairs-CMC at Alnylam Pharmaceuticals since November 2015, after previously holding the positions of Manager of Regulatory Affairs-CMC and Sr. CMC Technical Writer. Prior experience includes roles as Clinical Research Project Manager and Sr. Regulatory Coordinator at Dana-Farber Cancer Institute from 2014 to 2015, as well as various positions at Covance Laboratories from 2000 to 2014, including Quality Assurance Officer/Auditor, Principal Investigator, and Research Assistant. Melanie holds a Master of Science in Regulatory Affairs for Drugs, Biologics and Medical Devices from Northeastern University and a Bachelor of Science in Chemistry and Mathematics from the University of Wisconsin-Stevens Point.
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
31 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.